Navigation Links
Growth: the Good, the Bad, and the Ugly

Understanding the numbers

A risk capital financier with a portfolio perspective knows that many of her investments will fail. The winners have to generate high returns to make up for the losers. Some simple calculations suggest that given a 25-35% annualized return requirement, the winners will have to return 10-20 times what was invested (i.e. a $50,000 investment returns $500,00......

Full article >>> ince then, Aurora was bought by Vertex, and PanVera was re-sold to Invitrogen. According to BioSpace, there are about 100 people at the Madison facility.

The point to all this is that the comp......

Full article >>> inancing. New offices were renovated in the Madison east side industrial corridor. Employee count grew dramatically.

The plan was straightforward: grow the infrastructure, offer a unique value proposition, and advertise. Unfortunately, the market just wasnt there, or it wasnt ready, and the company couldnt meet projections. Then the venture market tightened, and it became clear that ......

Full article >>> th route, there are risks that cant be avoided. And growth companies often find that when something goes wrong, things get ugly really fast: creditors wont wait for payments, employees begin slipping away, and investors want quick-fix solutions.

The Milwaukee Journal-Sentinel wrote a solid review of what happ......

Full article >>>
'"/>

Source:wistechnology.com By Adam Bock 07/08/03


Related biology technology :

1. The Good, Bad, Ugly of Midwest Biotech in 2003
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Global Market for Bioproducts Should ... at a CAGR of 8.9%, This research ... into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseqâ„¢ ... developed with input from industry experts to ...
(Date:3/23/2017)...  BioPharmX Corporation (NYSE MKT: BPMX), a specialty ... today reported financial results for the quarter and ... an update on the company,s clinical development efforts ... are pleased to report that last year was ... Anja Krammer. "We achieved key clinical milestones and ...
Breaking Biology Technology:
(Date:3/9/2017)... , March 9, 2017 4Dx has ... World Lung Imaging Workshop at the University of Pennsylvania. ... invited to deliver the latest data to world leaders ... event brings together leaders at the forefront of the ... lung imaging. "The quality of the ...
(Date:3/2/2017)... 2017 Summary This report provides all ... partnering interests and activities since 2010. ... Read the full report: ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ...
(Date:2/28/2017)... 28, 2017   Acuant , a leading provider ... significant enhancements to new and core technologies building upon ... include mobile and desktop Acuant FRM TM facial ... a real time manual review of identity documents by ... the fastest and most accurate capture software to streamline ...
Breaking Biology News(10 mins):